These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 2783889)
1. Characterization of T-lymphocyte subpopulations infiltrating primary breast cancer. Bilik R; Mor C; Hazaz B; Moroz C Cancer Immunol Immunother; 1989; 28(2):143-7. PubMed ID: 2783889 [TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating CD4+ T lymphocytes in early breast cancer reflect lymph node involvement. Macchetti AH; Marana HR; Silva JS; de Andrade JM; Ribeiro-Silva A; Bighetti S Clinics (Sao Paulo); 2006 Jun; 61(3):203-8. PubMed ID: 16832552 [TBL] [Abstract][Full Text] [Related]
3. Identification and importance of lymphocyte subpopulations in the regional lymph nodes of breast cancer patients. Khuri N; Jothy SP; Shibata HR Can J Surg; 1989 Jan; 32(1):23-6. PubMed ID: 2463069 [TBL] [Abstract][Full Text] [Related]
4. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer. Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469 [TBL] [Abstract][Full Text] [Related]
5. T-cell markers in tumor-infiltrating lymphocytes of head and neck cancer. Snyderman CH; Heo DS; Chen K; Whiteside TL; Johnson JT Head Neck; 1989; 11(4):331-6. PubMed ID: 2502505 [TBL] [Abstract][Full Text] [Related]
6. Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. Kohrt HE; Nouri N; Nowels K; Johnson D; Holmes S; Lee PP PLoS Med; 2005 Sep; 2(9):e284. PubMed ID: 16124834 [TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating regulatory T cells, CD8/Treg ratio, and cancer stem cells are correlated with lymph node metastasis in patients with early breast cancer. Solis-Castillo LA; Garcia-Romo GS; Diaz-Rodriguez A; Reyes-Hernandez D; Tellez-Rivera E; Rosales-Garcia VH; Mendez-Cruz AR; Jimenez-Flores JR; Villafana-Vazquez VH; Pedroza-Gonzalez A Breast Cancer; 2020 Sep; 27(5):837-849. PubMed ID: 32180141 [TBL] [Abstract][Full Text] [Related]
8. Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma. Sheu BC; Hsu SM; Ho HN; Lin RH; Torng PL; Huang SC Cancer; 1999 Oct; 86(8):1537-43. PubMed ID: 10526283 [TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological significance of cytotoxic lymphocytes in breast cancer and draining lymph nodes]. Wang HY; He JJ; Shi QF; Lai BC; Ding HY; Zheng J; Wang YL Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):384-8. PubMed ID: 19781344 [TBL] [Abstract][Full Text] [Related]
10. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer. Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310 [TBL] [Abstract][Full Text] [Related]
11. Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NAC. Kaewkangsadan V; Verma C; Eremin JM; Cowley G; Ilyas M; Eremin O BMC Cancer; 2018 Feb; 18(1):123. PubMed ID: 29390966 [TBL] [Abstract][Full Text] [Related]
12. Predominance of helper-inducer T cells in mesenteric lymph nodes and intestinal lamina propria of normal nonhuman primates. James SP; Graeff AS; Zeitz M Cell Immunol; 1987 Jul; 107(2):372-83. PubMed ID: 2954655 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. Liyanage UK; Moore TT; Joo HG; Tanaka Y; Herrmann V; Doherty G; Drebin JA; Strasberg SM; Eberlein TJ; Goedegebuure PS; Linehan DC J Immunol; 2002 Sep; 169(5):2756-61. PubMed ID: 12193750 [TBL] [Abstract][Full Text] [Related]
14. Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer. Whitford P; Mallon EA; George WD; Campbell AM Br J Cancer; 1990 Dec; 62(6):971-5. PubMed ID: 2124138 [TBL] [Abstract][Full Text] [Related]
16. Tumor infiltrating lymphocytes differ in invasive micropapillary carcinoma and medullary carcinoma of breast. Guo X; Fan Y; Lang R; Gu F; Chen L; Cui L; Pringle GA; Zhang X; Fu L Mod Pathol; 2008 Sep; 21(9):1101-7. PubMed ID: 18469794 [TBL] [Abstract][Full Text] [Related]
17. Nodal status in luminal A invasive breast cancer: relationships with cytotoxic CD8 + and regulatory FOXP3 + cells tumor-associated infiltrate and other prognostic factors. Glajcar A; Łazarczyk A; Tyrak KE; Hodorowicz-Zaniewska D; Streb J; Okoń K; Szpor J Virchows Arch; 2021 Nov; 479(5):871-882. PubMed ID: 34117905 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer. Morton BA; Ramey WG; Paderon H; Miller RE Cancer Res; 1986 Apr; 46(4 Pt 2):2121-6. PubMed ID: 3081262 [TBL] [Abstract][Full Text] [Related]
19. Functional and phenotypic analysis of lymphocytes in head and neck cancer. Snyderman CH; Heo DS; Johnson JT; D'Amico F; Barnes L; Whiteside TL Arch Otolaryngol Head Neck Surg; 1991 Aug; 117(8):899-905. PubMed ID: 1832546 [TBL] [Abstract][Full Text] [Related]
20. Lymphocyte subpopulations in children with abnormal lymphatic circulation. Garty BZ; Levinson AI; Danon YL; Wilmott R; Douglas SD J Allergy Clin Immunol; 1989 Oct; 84(4 Pt 1):515-20. PubMed ID: 2529303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]